Second-line anti-leprosy drugs: Indian experience

Second-line anti-leprosy drugs: Indian experience

Bibliographic Details
Main Author:	Vivek V Pai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Indian Journal of Drugs in Dermatology
Online Access:	http://www.ijdd.in/article.asp?issn=2455-3972;year=2020;volume=6;issue=1;spage=1;epage=4;aulast=Pai

Similar Items

Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
by: Diana N J Lockwood, et al.
Published: (2012-01-01)

Azathioprine and cyclosporin A as second line treatments for severe leprosy type reactions
by: Marlowe, Sharon Nalini Singh
Published: (2005)

Drug therapy of leprosy
by: A. A. Kubanov, et al.
Published: (2017-08-01)

Newer Chemortherapeutic Agents In Leprosy
by: Ganapati R, et al.
Published: (1996-01-01)

Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
by: Camilo Beltrán-Alzate, et al.
Published: (2016-10-01)

Designing and evaluation of rapid molecular assays for first and second-line anti-tuberculosis drugs
by: M Arjomandzadegan, et al.
Published: (2015-01-01)

Aflibercept as a second-line therapy in metastatic colorectal cancer: A limited Indian experience
by: Govind Babu, et al.
Published: (2016-01-01)

Principles Currently Governing Leprosy Elimination
by: Ganapati R, et al.
Published: (1997-01-01)

Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study
by: Cheng S, et al.
Published: (2021-03-01)

ANALYSIS OF SECONDARY RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO SECOND-LINE ANTI-TUBERCULOSIS DRUGS IN CASABLANCA
by: G. Momen, et al.
Published: (2018-12-01)

EXPERIENCE IN THE LEPROSY CONTROL PROGRAMME
by: P G Kalthoff
Published: (2003-01-01)

Interesting and unusual clinical presentations in leprosy at a referral center
by: Pritam U Tayshetye, et al.
Published: (2013-01-01)

Dirt, Saliva and Leprosy: Anti-Inflammatory and Anti-Infectious Effects
by: Helieh S. Oz
Published: (2019-03-01)

Role of clofazimine in management of reactions in leprosy: A brief overview
by: V V Pai
Published: (2015-01-01)

Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
by: Rajendra Prasad, et al.
Published: (2021-01-01)

Knowledge and Attitude about Leprosy among Indian Dental Students in Faridabad
by: Meena Jain, et al.
Published: (2016-03-01)

Novel HLA Class I Alleles Associated with Indian Leprosy Patients
by: U. Shankarkumar, et al.
Published: (2003-01-01)

Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines.
by: Diana N J Lockwood, et al.
Published: (2019-10-01)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
by: Osei-Wusu S, et al.
Published: (2018-02-01)

FREQUENCY AND CHARACTERISTICS OF ADVERSE REACTIONS TO SECOND LINE ANTI-TUBERCULOSIS DRUGS IN THOSE ILL WITH MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. A. Toktogonova
Published: (2017-11-01)

De Novo Histoid Leprosy
by: Pooja Pandey, et al.
Published: (2015-01-01)

Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
by: Idah Mokhele, et al.
Published: (2021-06-01)

Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains
by: Francesca Barletta, et al.
Published: (2014-12-01)

Anti-leprosy vaccines: current status and future prospects.
by: Kartikeyan S, et al.
Published: (1991-10-01)

Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience
by: BJ Srinivasa, et al.
Published: (2018-06-01)

A Study of the Anti-Inflammatory, Anti-Microbial and Immunomodulatory Properties of Thalidomide in Leprosy
by: Tadesse Argaw, Azeb
Published: (2004)

Product, Process and Packaging Optimization for Development of Stable Oral Capsule Formulation of Second-line Anti- Tubercular drug
by: Amit Mukharya, et al.
Published: (2011-01-01)

Comparison of efficacy between second line anti-androgen drugs for metastatic castration-resistent prostate cancer patients
by: Po-Jung Su, et al.
Published: (2018)

Nurse's experiences of leprosy related stigma in Ghana
by: Bergman, Love, et al.
Published: (2014)

Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis.
by: Anuj Tiwari, et al.
Published: (2020-08-01)

Household expenditure on leprosy outpatient services in the Indian health system: A comparative study.
by: Anuj Tiwari, et al.
Published: (2018-01-01)

Targeted drugs in the second line anticancer therapy of disseminated colorectal cancer
by: K. A. Vorontsova, et al.
Published: (2015-12-01)

Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective.
by: Syed Beenish Rufai, et al.
Published: (2020-01-01)

Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?
by: Luíse L. Chaves, et al.
Published: (2020-12-01)

Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice
by: Eleonora Lai, et al.
Published: (2021-05-01)

Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China
by: Yi Hu, et al.
Published: (2016-01-01)

Second line anti-cancer therapy for metastatic colorectal cancer: treatment strategy
by: K. A. Vorontsova, et al.
Published: (2015-12-01)

Lazarine leprosy: A unique phenomenon of leprosy
by: Vaishali Wankhade, et al.
Published: (2020-01-01)

Borderline tuberculoid leprosy associated with histoid leprosy
by: Angoori Gnaneshwar Rao
Published: (2016-01-01)

Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis
by: V. R. Mkrtchyan, et al.
Published: (2015-10-01)